An Endorsement of the Removal of Race From GFR Estimation Equations: A Position Statement From the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

GFR Estimation in Japan and China: What Accounts for the Difference?

A Decade After the KDOQI CKD Guidelines: Impact on Research

Definition and Classification of CKD: The Debate Should Be About Patient Prognosis—A Position Statement From KDOQI and KDIGO

Performance of Serum β2-Microglobulin– and β-Trace Protein–Based Panel Markers and 2021 Creatinine- and Cystatin-Based GFR Estimating Equations in Pakistan

Cystatin C: Research Priorities Targeted to Clinical Decision Making

Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation?

A Decade After the KDOQI CKD Guidelines: Impact on NKF-KDOQI

Do We Need to Check Our Genes for a Correct Estimate of GFR?

Estimating GFR from serum creatinine concentration: Pitfalls of GFR-estimating equations

Assessment of Proteinuria

A Decade After the KDOQI CKD Guidelines: Impact on the United States and Global Public Policy

Rationale and Strategies for Early Detection and Management of Diabetic Kidney Disease

Risk for Incident Renal Dialysis in a Managed Care Population

On Being Better Kidney Doctors: Understanding Trajectories, Probabilities, Predictability, and People

A Prospective Cross-Sectional Study on the Performance of the 2021 CKD-EPI Equations Without Race in a Multiracial Population of Adults With Solid Tumors in Brazil